Investors

Harnessing the therapeutic power of cannabinoids

Chair's Welcome

Welcome to OCT.

Engaging with our investors is very important to us and we want you to be well briefed about the Company, our activities and our drug development programmes.

Business model & strategy

Click ‘learn more’ for a breakdown of our business model and strategy.

Annual report & interim results

Click ‘learn more’ for our annual reports and interim results.

Board of directors

Click ‘learn more’ for details on our Board of directors.

Share price information

Regulatory news

Financial calendar

Investor advisors

Research reports

Corporate governance

Key shareholders

Key documents

Investor Q&A